Elon Musk’s proposed takeover of Twitter has ruffled many feathers among professional commentators. “Musk is the wrong leader for Twitter’s vital mission,” read one Bloomberg headline. The network also insisted, “Nothing in the Tesla CEO’s track record suggests he will be a careful steward of an important media property.” “Elon Musk is the last person who should take over Twitter,” wrote Max Boot in The Washington Post, explaining that “[h]e seems to believe that on social media anything goes. For democracy to survive, we need more content moderation, not less.” The irony of outlets owned by Michael Bloomberg and Jeff Bezos warning of the dangers of permitting a billionaire oligarch to control our media was barely commented upon.
Elon Musk Is Not a Renegade Outsider – He’s a Massive Pentagon Contractor
In recent years NATO – essentially the USA and Western Europe – has bared its fascist roots through multiple interventions across four continents.
NATO’s fascist history
Nikolay Patrushev, Secretary of the Russian Security Council, in an interview with Rossiyskaya Gazeta, spoke about the tasks of the Russian special operation and the role of the United States in supporting neo-nazis. And also – about the near future of Europe, the Russian gold and foreign exchange reserves and sanctions. And also about what changes await our country in the near future.
Patrushev: The West Has Created an Empire of Lies Presupposing the Destruction of Russia
1st Area Medical Laboratory Soldiers train with Ukrainian military doctors (Archived)
KYIV, Ukraine – Soldiers from the Aberdeen Proving Ground, Maryland-based 1st Area Medical Laboratory and Fort Detrick, Maryland-based U.S. Army Medical Institute of Infectious Diseases trained with Ukrainian military medical professionals.
Six 1st AML Soldiers and a USAMRIID Soldier deployed to the Ukrainian capital of Kyiv from June 3 – 18.
Maj. Jang-woo Lee, the 1st AML chief of Endemic Disease and Biological Warfare Assessment, said the American Soldiers supported the establishment of a Ukraine Ministry of Defense Biological Mobile Diagnostics Unit.
The U.S. Defense Threat Reduction Agency training initiative focused on polymerase chain reaction diagnostic testing and field identification of biological agents. Lee said the U.S. troops delivered training lectures, hands-on training and field training exercises with Ukrainian troops in laboratory and field environments, using commercially available materials.
“U.S. subject matter experts trained their Ukrainian counterparts who will provide the training to their Soldiers to increase the readiness of the deployable mobile laboratories,” said Lee, an Operation Enduring Freedom veteran who is originally from South Korea. “I believe that the impact and influence of this effort will be greater than the two-week training.”
…
The 1st Area Medical Laboratory is part of the 20th Chemical, Biological, Radiological, Nuclear, Explosives (CBRNE) Command, the U.S. Department of Defense’s only multifunctional all hazards headquarters.
From 19 military installations in 16 states, 20th CBRNE Command units deploy globally to take on the world’s most dangerous weapons and hazards.
…
The one-of-a-kind U.S. Army laboratory has deployed often to support military operations, including the 2014-2015 effort to contain the Ebola outbreak in West Africa.
Soldiers from 1st AML also served in seven different overseas locations to support the COVID-19 response, including U.S. military hospitals in Germany, South Korea and Japan.
Amazon’s Twitch bans channels after researchers find pro-Russia propaganda
Related:
Amazon-Owned Twitch Spreading Russian Misinformation on Ukraine
George Soros admits to funding the Ukraine crisis
Pierre Omidyar co-funded Ukraine revolution groups with US government, documents show
The FDA loves horse medicine if it’s really expensive, still under patent, and toxic
Related:
Study shows effectiveness of pill form of remdesivir to treat COVID-19 in mice (Ralph Baric & Gilead Sciences)**
Molnupiravir & Ivermectin’s Equine Connections
An emerging antiviral takes aim at COVID-19
[Molnupiravir] EIDD-2801’s story starts years before the coronavirus crisis. In 2014, Painter and his colleagues at Emory University began a project funded by the Defense Threat Reduction Agency to find an antiviral compound that could fight Venezuelan equine encephalitis virus (VEEV). During the Cold War, both the US and the Soviet Union studied VEEV as a potential biological weapon. Typically transmitted through mosquito bites, VEEV causes high fevers, headaches, and sometimes encephalitis, swelling of the brain that can be deadly.
…
In late 2019, Painter got a contract from the National Institute of Allergy and Infectious Diseases* to move EIDD-2801 into Phase I clinical trials for influenza. The plan was to file an investigational new drug application and find a partner to help with the clinical work.
…
Just as the team was contemplating its next move, word of a virus spreading in Wuhan, China, was starting to make news. One of Painter’s collaborators, UNC coronavirus expert Ralph Baric**, immediately alerted him that the new pathogen was probably a coronavirus—one that EIDD-2801 could potentially combat.
Denison*** says the research team knew a coronavirus outbreak was inevitable. “Every single one of our grants, every single one of our papers predicted that this event was going to happen that’s occurring right now,” he says. “The whole goal of our drug development was to plan for this.”
*Anthony Fauci, director of NIAID.
**Ralph Baric, patents.
***Mark Denison (Denison Lab/Vanderbilt University Medical Center & Gilead Sciences)
Ms. Cat’s Chronicles 
You must be logged in to post a comment.